ATAGI recommendations

Use of 1 dose of 9vHPV in immunocompetent females and males aged ≥9 years

 

9-valent human papillomavirus vaccine (Gardasil 9, 9vHPV)

Coversheet on evidence assessment by ATAGI using the GRADE framework for 1 dose of 9vHPV in immunocompetent females and males aged ≥9 years

 

GRADE assessment for 1 dose of 9vHPV

Compared against no vaccine/control vaccine/placebo in immunocompetent females and males aged ≥9 years

Compared against 2 or 3 doses of 9vHPV in immunocompetent females and males aged ≥9 years

 

Note: These GRADE documents should be read as a supplement to the Australian Immunisation Handbook recommendations.

View the HPV disease chapter in the Handbook here

Last updated February 2024